HULL ANDREW has filed 7 insider transactions across 1 company since December 2023.
Most recent transaction: a grant/award of 1750 shares of InMed Pharmaceuticals Inc. ($INM) on December 19, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | InMed Pharmaceuticals Inc. | $INM | HULL ANDREW | Director | A | Employee Stock Option (Right to Buy) | 1750 | $0.00 | 2,711.0000 | 3,954,549 | 182.10% | 0.04% |
| Dec. 15, 2025 | InMed Pharmaceuticals Inc. | $INM | HULL ANDREW | Director | H | Employee Stock Option (Expiration) | 14 | $0.00 | 961.0000 | 3,954,549 | 1.44% | 0.00% |
| Jan. 11, 2025 | InMed Pharmaceuticals Inc. | $INM | HULL ANDREW | Director | H | Employee Stock Option (Expiration) | 2 | $0.00 | 975.0000 | 706,546 | 0.20% | 0.00% |
| Dec. 20, 2024 | InMed Pharmaceuticals Inc. | $INM | HULL ANDREW | Director | A | Employee Stock Option (Right to Buy) | 550 | $0.00 | 977.0000 | 620,127 | 128.81% | 0.09% |
| Jan. 14, 2024 | InMed Pharmaceuticals Inc. | $INM | HULL ANDREW | Director | H | Employee Stock Option (Expiration) | 42 | $0.00 | 8,542.0000 | 398,673 | 0.49% | 0.01% |
| Feb. 21, 2024 | InMed Pharmaceuticals Inc. | $INM | HULL ANDREW | Director | P | Common Stock | 37500 | $0.39 | 38,258.0000 | 398,673 | 4947.23% | 9.41% |
| Dec. 23, 2023 | InMed Pharmaceuticals Inc. | $INM | HULL ANDREW | Director | A | Employee Stock Option (Right to Buy) | 7100 | $0.00 | 8,584.0000 | 166,410 | 478.44% | 4.27% |